Zogenix, Inc. (NASDAQ: ZGNX) is committed to developing and commercializing transformative therapies for people living with rare diseases that can dramatically improve the lives of patients and their families.
We take pride in being a company who hires exceptional people who exemplify high standards and a passion to create significant value and benefits for healthcare professionals and their patients, our employees and our shareholders.
Strictly Necessary Cookies
Zogenix uses some cookies that are strictly necessary for the website to function correctly and securely and cannot be switched off in our systems. Cookies that are strictly necessary are not used for marketing purposes, and they do not need your consent to be installed. Strictly necessary cookies allow us to maintain the safety and security of our website, and enable basic features, such as authenticating account users, or allowing you to sign in securely. You can still decide to disable these types of cookies, but if you choose to do so, then you will not be able to use the full functionality of the website. To the extent the use of these cookies may include processing of your personal data, the processing will be based on our legitimate interests in providing secure and functioning website features and services, including secure authentication and login procedures and management of your cookie choices.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Please enable Strictly Necessary Cookies first so that we can save your preferences!